INTRODUCTION
HIV/AIDS is still one of the top 10 causes of premature death worldwide, with substantial differences between high-, middle-, and low-income countries. Worldwide, HIV/AIDS is associated with health inequality in all age groups but differences are more marked in the 20-40 years band [1] . The post-2015 global health agenda focuses on universal health coverage to meet basic healthcare needs to achieve the target of zero disease for HIV/AIDS, along with tuberculosis and malaria [2] . However, even in a context of universal health care, populations' health outcomes are heavily influenced by social, cultural, environment, and economic factors, known as the 'social determinants of health'. Those determinants, conceptualized in the gender, race/ ethnic, and socioeconomic axes, influence the life course of a person with HIV infection from the moment of HIV acquisition, and will jeopardize the success of the 90 : 90 : 90 United Nations Programme on HIV/AIDS (UNAIDS) initiative which aims to end AIDS by 2030 through the diagnoses of 90% of all persons living with HIV/AIDS (PLWHA), through the linkage to care of 90% of those diagnosed and through the achievement of viral suppression in 90% of the later [3] .
The benefits of early antiretroviral therapy (ART) at the individual and the population level, which have led to remarkable increases in life expectancy and healthier lives, rely on equitable access and successful lifelong treatment retention [4] [5] [6] [7] [8] . However, although the life expectancy of many HIV-infected individuals on combined Antiretroviral Therapy (cART) with restored CD4 þ cell count is similar to the general populations in countries where HIV care is free and treatment is provided universally, some vulnerable and key populations still suffer from excess mortality [9,10]. Indeed, even in contexts of universal health care, barriers to healthcare access, to engagement, and retention in care do exist. Some key populations are particularly affected; persons who inject drugs (PWID), sex workers, transgender individuals, MSM, women, and/or migrants, some of them belonging to several key groups thus adding layers of vulnerability. Barriers to access HIV testing and optimal HIV care are multiple and include unstable housing, low socioeconomic status, marginalization, and/or exposure to extreme violence [11] . Further, sexual partnerships with fear of HIV disclosure, stigma, loneliness, and the burden of child care activities are additional factors to be considered in women [12 & ,13] . Special situations arise in migrants [10, 14] , which relate to the conditions of migration, employment insecurity, exposure to difficult or oppressive work environments, separation from family and friends and mechanisms, and motivations for migrating. For newly arrived migrants, particularly the undocumented, barriers to access health services because of administrative barriers, unfamiliarity with the host environment and poor communication skills do matter too [15 && ,16] . Nevertheless, even for people accessing to and compliant with ART, social disadvantage is associated with excess of mortality because of non-AIDS causes which are also present in HIV-negative populations of lower socioeconomic status.
In addition, in high-income countries, differences in mortality rates between HIV-infected people living in Europe and North America are substantial. The higher mortality rates of PLWHA in North America compared with Europe's are attributable to a myriad of different factors, including behavioral characteristics and comorbidities, but mostly because of the higher representation of socially disadvantaged patients; African-American and Hispanics in the United States and the First Nations populations in Canada [17] . The ART Cohort Collaboration reported lower mortality after ART initiation in HIV-positive migrants living in Europe and Canada compared with native populations supporting 'healthymigrant' effects, and showed higher mortality in First Nations in Canada and African-Americans and Hispanics in the United States compared with largely White study participants [18] . Furthermore, the higher mortality of First Nations in Canada was explained by higher non-AIDS mortality rates attributable to substance use and underlying socioeconomic inequalities, and the lower mortality rates in migrants was attributable to lower rate of non-AIDS defining conditions, associated to healthier lifestyles.
In various European studies, HIV-infected women have higher life expectancy than HIVinfected men [19] [20] [21] reflecting the life expectancy patterns of the general population which ART has rendered visible. In North America, though, life expectancy in women is lower than men's, as the women living with HIV in North America, largely the United States, have a poorer socioeconomic status to start with, given that their epidemic is driven by past or current drug use, racial, and socioeconomic disadvantage [22,23 & ,24] . So, differences in cohort demographics and healthcare access and utilization can explain such discrepancies between European and North American women, bearing in mind that Canada, unlike the United States, has a universal healthcare system.
It is undoubtable that lifestyle factors such as smoking, excessive alcohol intake, and drug use account for large and preventable differences in mortality. However, survival upon HIV infection is dependent on early diagnosis and timely
KEY POINTS
Worldwide, HIV/AIDS is associated with inequality in health in all age groups. Even in a context of universal healthcare, the health outcomes of populations are heavily influenced by social, cultural, environment, and economic factors known as 'social determinants' of health.
Risk factors for late presentation and delayed ART initiation are male sex, older age, particularly people older than 50, IDU, heterosexual transmission, and migrant origin -particularly from sub-Saharan Africa or Latin America. A lower socioeconomic position is associated with late presentation in most studies.
After ART initiation, although retention into care is lower in PWID and migrants, similar or lower mortality rate are reported in migrants from sub-Saharan Africa or Latin America when compared with native populations, consistent with 'healthy migrant effects', though heterogeneity within migrant groups is observed.
In high-income countries, differences in mortality rates between HIV-infected people living in Europe and in North America are substantial with higher mortality in socially disadvantaged racial groups than in native White populations, and in women than in men in North America but not in Europe. Such results are explained by differences in socioeconomic status and access to care. treatment, followed by linkage to and retention in care, coupled with adherence to medications.
IMPACT OF LATE HIV DIAGNOSIS AND DELAYED TREATMENT ON MORTALITY AND SOCIODEMOGRAPHIC FACTORS
In Europe, where health care in general is universal in most countries, late HIV diagnosis and delayed ART initiation are major prognostic factors [19] . Up to 50% of individuals throughout Europe present late to care in the course of HIV infection, that is, with CD4 þ lower than 350/ml or with an AIDSdefining event [25,26 & ], and this is associated with premature elevated mortality because of HIV/AIDS within the first 6 months to 1 year after entry into care [25, 27, 28] . The excess risk of mortality of persons diagnosed late can persist until 4 years after diagnosis though, after 4 years, differences become nonsignificant, numbers of deaths decrease and causes of death change to liver-related conditions and non-AIDS malignancies [28] . In the last 10 years, although percentages of late presenters have declined from 54-57 to 40-50%, the reduction is mainly significant in MSM, and is still insufficient [25, 28] . Risk factors for late presentation and delayed ART initiation are male sex (for transmission routes other than MSM), older age, particularly people older than 50, injecting drug use (IDU), heterosexual transmission, and migrant origin, particularly from sub-Saharan Africa or Latin America [25,28,29
Although late presentation has shown to be deleterious for all PLWHA [25, 27, 28] , disease progression appears to be more rapid among older individuals, and the effect of delaying ART from 500 to 350 or 200/ml on survival is the most detrimental in the oldest persons [19, 32] .
The relationship between socioeconomic position and late presentation has been approached in different ways. Given that socioeconomic status is very hard to measure, several proxies have been used such as individual educational level and individual income or neighborhood socioeconomic position. Low education attainment (primary school or less and lower secondary school compared with university) is an independent predictor of late presentation [28] , and is associated with lower median CD4 þ cell count at ART initiation. In large multicenter European cohort collaboration, the gradient of the association between educational attainment and late HIV diagnosis was more pronounced among men than women [33 & ]. This pattern was attributable to universal HIV-testing programs targeting all pregnant women for prevention of mother-to-child transmission in Europe, which de facto bends HIV testing toward a more general testing approach rather than to high-risk approach. Residence in neighborhoods of low socioeconomic position is also associated with late HIV 
RESPONSES TO ANTIRETROVIRAL THERAPY: KEY POPULATION AND SOCIOECONOMIC FACTORS
After entry into care and ART initiation, sustained virological response and CD4 þ cell count recovery determine survival. These outcomes are conditioned by drug adherence [36] and retention into care. Overall, PWID, especially men, have the worst survival and MSM have the best [20, 21] . Older people, PWID and migrants have poorer virological and immunological responses to ART in various contexts [22,24,29 & ,37] . The underlying reasons for these poorer outcomes is their lower retention in the successive stages of the HIV continuum of care cascade, including higher rate of losses to follow-up, particularly soon after entry [22, 24, 38] . However, in a study of people retained in care and on ART for more than 6 months, the only factors associated with viral replication were social deprivation and younger age [39] .
These findings need to be contextualized to the settings where they took place. Thus, the relative importance of some of the sociodemographic factors versus others may vary across the different studies and contexts. For example, while the race/ ethnicity axis is very relevant in studies from the United States, this is less of an issue in Western European countries, where the socioeconomic axis is more relevant.
Comparable or lower mortality rates have been reported in migrants from sub-Saharan Africa or Latin America with that of native populations'. This has been recently reported in studies from Spain and France, though it has to be acknowledged that migrants experience poorer virological and immunological responses to ART and an increased risk of AIDS [37, 40] . This discrepancy between lower mortality and higher AIDS is consistent with lower non-AIDS mortality and higher tuberculosis incidence in migrants [18, 41] . The COHERE Collaboration has recently shown no significant differences in mortality by geographical origin among MSM, highlighting the heterogeneity within migrant groups once large datasets are examined [27,31 && ]. In heterosexual populations, most migrant men had a mortality rate which is lower than or equal to that of native HIV-positive men, whereas no group of migrant women had mortality lower than that of native women. High mortality is identified in heterosexual men from Latin America and heterosexual women from the Caribbean [31 && ]. Sociocultural determinants were not assessed in these studies [27,31 && ,37,40]. The ART Cohort Collaboration reported lower mortality after ART initiation in HIV-positive women in Europe compared with men's, with larger betweensex differences among heterosexually infected patients than among injecting drug users, and larger between-sex differences in non-AIDS than in AIDS mortality [42 & ]. The lower mortality in women was largely because of non-AIDS-related causes: non-AIDS infections, liver-related death, cardiovascular diseases, and non-AIDS malignancies, where the causal role of smoking has been proven. Consistent with previous studies, no differences in all-cause or cause-specific mortality between men and women were found in Canada and in the Unites States. In the United States, after adjustment on demographic factors, AIDS and neighborhood poverty, Black men and women had higher mortality compared with non-Hispanic Whites [23 & ,43], as have people born in the Unites States and people living in area of high poverty [43] . Such results may be because of differences in socioeconomic status and access to care. Indeed, in a study on Medicaidenrolled HIV/Hepatitis C (HCV) coinfected patients on ART, lower adherence (but nor sex neither race/ ethnicity) is associated with survival [44] .
In the context of universal free HIV care, when socioeconomic status is investigated in people on treatment, results are conflicting. Overall, in Europe, lower educational level -a good proxy for socioeconomic status -is associated with worse virological and immunological responses to ART and lower survival, after adjustment for sex, age, HIV transmission group, geographical origin, AIDS, CD4 þ , and viral load at ART initiation [45] . In Switzerland, residence in neighborhoods of low socioeconomic position is associated with lower response to ART but not with mortality [34 & ]. In Spain, people with lower education have worse survival than people with university education but no differences are found according to district household income [20] . In France, social vulnerability, measured by a composite indicator using education (having a highschool certificate), employment (being employed) and housing (stable housing, comfortable housing), is a major independent mortality risk factor [46 & ]. In Denmark, outside the context of PWID, though low educational attainment is not associated with viral suppression following ART, the mortality rate ratio is higher in HIV-infected people with low education attainment compared to people with medium and high education attainment, consistent with the mortality patterns in the general population. In this study, low education is associated with lifestylerelated mortality, mainly smoking and alcoholrelated deaths, but not with AIDS-related mortality, suggesting that increased mortality in HIV-infected patients with low education can be because of risk factors unrelated to HIV [35 & ].
CONCLUSION
Socioeconomic factors explain a substantial proportion of the differences in late access to HIV testing, HIV care, and HIV-related outcomes following ART in PLWHA, though the relative importance of some factors versus others varies across the different studies and contexts. Ensuring free and universal access to health care to all people is pivotal -but not enoughto ensure expansion of HIV testing, HIV transmission control, early access to ART, adherence to ART, retention in care, and increase in survival. The fact that social disparities lead to differences in prognosis of HIV even in countries with free access to HIV health care highlight the need of additional efforts with interventions adapted to the specificities of each HIV key populations, as well as policies that fight inequality at the macroeconomic and social level.
Acknowledgements
None.
Financial support and sponsorship
The work has been partially funded by the RD12/0017/ 0018 project as part of the Plan Nacional R þ D þ I and cofinanced by ISCIII-Subdireccion General de Evaluacion and the FondoEuropeo de Desarrollo Regional (FEDER).
Conflicts of interest
There are no conflicts of interest. (1997) (1998) (1999) (2000) (2001) (2002) (2003) (2004) (2005) (2006) (2007) (2008) (2009) (2010) (2011) (2012) (2013) , no significant difference in mortality was identified by geographical origin in MSM. In heterosexual populations, most migrant men had mortality lower than or equal to that of native men, whereas no group of migrant women had mortality lower than that in native women. High mortality was identified in heterosexual men from Latin America and heterosexual women from the Caribbean. Compared with that in the native population, mortality in injecting drug users was similar or low for all migrant groups. This study shows how the characteristics of and risks faced by migrant populations with HIV differ for men and women and for populations infected heterosexually, by sex between men, or by IDU. , and 31% with uncompleted basic, basic, secondary, and tertiary education, respectively, presented with advanced HIV disease (AHD). Compared to patients with tertiary education, adjusted odds ratios of AHD were 1.72 for uncompleted basic, 1.39 for basic, and 1.20 for secondary education. In unadjusted and adjusted analyses, median CD4 þ cell count at cART initiation was lower with poorer educational level. Socioeconomic inequalities in delayed HIV diagnosis and initiation of cART are present in European countries with universal healthcare systems and individuals with lower educational level do not equally benefit from timely cART initiation.
REFERENCES AND RECOMMENDED READING

34.
& Gueler A, Schoeni-Affolter F, Moser A, et al. Neighbourhood socio-economic position, late presentation and outcomes in people living with HIV in Switzerland. AIDS 2015; 29:231-238. The article shows that a low neighbourhood socioeconomic position of HIVinfected people is associated with late presentation to diagnosis and care, and a lower likelihood of undetectable viral load on ART, although no association was demonstrated for mortality. It is the only one article in Europe exploring a geographical deprivation index in HIV-infected people in Europe. 35.
